Cano Health, Inc.
CANOQ
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.85% | 14.55% | 21.60% | 24.91% | 42.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.85% | 14.55% | 21.60% | 24.91% | 42.30% |
| Cost of Revenue | 18.86% | 31.99% | 36.16% | 33.55% | 40.50% |
| Gross Profit | -103.29% | -81.21% | -60.24% | -26.90% | 54.54% |
| SG&A Expenses | -17.15% | -15.42% | -5.72% | 11.47% | 34.60% |
| Depreciation & Amortization | -1.61% | 17.03% | 29.82% | 42.56% | 57.79% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.21% | 26.62% | 31.86% | 33.01% | 40.14% |
| Operating Income | -346.82% | -389.53% | -279.58% | -214.27% | -1.83% |
| Income Before Tax | -211.25% | -158.24% | -802.08% | -885.40% | -386.20% |
| Income Tax Expenses | -265.18% | -184.14% | -135.36% | -149.94% | 183.42% |
| Earnings from Continuing Operations | -210.20% | -156.52% | -791.55% | -843.29% | -385.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 111.45% | 128.15% | 705.39% | 622.07% | 203.31% |
| Net Income | -315.95% | -186.78% | -892.03% | -1,263.31% | -1,259.76% |
| EBIT | -346.82% | -389.53% | -279.58% | -214.27% | -1.83% |
| EBITDA | -2,250.70% | -72,225.74% | -1,189.88% | -614.78% | 65.34% |
| EPS Basic | -191.27% | -141.12% | -758.85% | -857.05% | -873.50% |
| Normalized Basic EPS | -92.87% | -22.17% | 21,977.49% | 650.47% | 148.21% |
| EPS Diluted | -201.22% | -152.32% | -149.66% | -92.22% | -25.45% |
| Normalized Diluted EPS | -72.76% | -9.22% | 5,626.31% | 1,849.68% | 189.51% |
| Average Basic Shares Outstanding | 42.90% | 25.71% | 28.19% | 31.86% | 30.73% |
| Average Diluted Shares Outstanding | 12.87% | 14.17% | 15.11% | -5.75% | 12.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
